Heart Biomarker Evaluation in Apnea Treatment
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 318 participants.
Also called NCT01086800
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 318 participants
- Registry
-
NCT01086800
-
- Other papers using this trial's data
- CPAP versus oxygen in obstructive sleep apnea
- Can improvements in sleep quality positively affect serum adiponectin-levels in patients with obstructive sleep apnea?
- The association between the effective apnea-hypopnea index and blood pressure reduction efficacy following CPAP/oxygen treatment
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01086800. Randomized; single masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2012-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Heart Biomarker Evaluation in Apnea Treatment
- Acronym
- HeartBEAT
- Condition
- Cardiovascular Disease
- Condition
- Obstructive Sleep Apnea
- Condition
- Coronary Artery Disease
- Intervention (Other)
- Healthy Lifestyles and Sleep Education plus PAP
- Intervention (Other)
- Healthy Lifestyles and Sleep Education plus Supplemental Oxygen
- Intervention (Other)
- Healthy Lifestyles and Sleep Education
- Lead sponsor
- Brigham and Women's Hospital
- Collaborator
- Case Western Reserve University
- Collaborator
- Partners HealthCare
- Collaborator
- Johns Hopkins University
- Collaborator
- VA Boston Healthcare System
Record details
- Record id
cardio:ct-nct01086800- Content hash
a2aa65b71da94754057e3a3bd3a3ed51f87dc2abc3dd81d27b95e9b6ffd372ae